Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

182 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Treatment of hepatocellular carcinoma: present and future.
Genco C, Cabibbo G, Maida M, Brancatelli G, Galia M, Alessi N, Butera G, Genova C, Romano P, Raineri M, Giarratano A, Midiri M, Cammà C. Genco C, et al. Among authors: genova c. Expert Rev Anticancer Ther. 2013 Apr;13(4):469-79. doi: 10.1586/era.13.21. Expert Rev Anticancer Ther. 2013. PMID: 23560841 Review.
Survival of patients with hepatocellular carcinoma (HCC) treated by percutaneous radio-frequency ablation (RFA) is affected by complete radiological response.
Cabibbo G, Maida M, Genco C, Alessi N, Peralta M, Butera G, Galia M, Brancatelli G, Genova C, Raineri M, Orlando E, Attardo S, Giarratano A, Midiri M, Di Marco V, Craxì A, Cammà C. Cabibbo G, et al. Among authors: genova c. PLoS One. 2013 Jul 29;8(7):e70016. doi: 10.1371/journal.pone.0070016. Print 2013. PLoS One. 2013. PMID: 23922893 Free PMC article.
3D CT scan for perioperative identification of anatomical variations of lungs.
Galluzzo A, Fatica F, Caternicchia F, Geraci G, Mancuso G, Raffaele F, Genova C, Cocchiara G, Midiri M, Cajozzo M. Galluzzo A, et al. Among authors: genova c. Future Oncol. 2016 Dec;12(23s):27-30. doi: 10.2217/fon-2016-0344. Epub 2016 Oct 3. Future Oncol. 2016. PMID: 27690632 Free article.
Improved overall survival in patients developing endocrine toxicity during treatment with nivolumab for advanced non-small cell lung cancer in a prospective study.
Albertelli M, Rossi G, Nazzari E, Genova C, Biello F, Rijavec E, Dal Bello MG, Patti L, Tagliamento M, Barletta G, Morabito P, Boschetti M, Dotto A, Campana D, Ferone D, Grossi F. Albertelli M, et al. Among authors: genova c. J Endocrinol Invest. 2024 Apr 29. doi: 10.1007/s40618-023-02268-0. Online ahead of print. J Endocrinol Invest. 2024. PMID: 38683497
182 results